Quilizumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Quilizumab
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target IGHE
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
Formula C6492H10046N1728O2023S44
Molar mass 146.1 kg/mol

Quilizumab (INN) is a humanized monoclonal antibody designed for the treatment of asthma.[1] It binds to IGHE.[2]

This drug was developed by Genentech.

References[edit]

  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Quilizumab, American Medical Association.
  2. ^ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 106" (PDF). WHO Drug Information. 25 (4).